持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2025/02/21 | 日証協 | 167,767株 | -10.38% | 143,162株 | -48.83% | 154,875株 | -2.74% | 8,173株 | -60.68% |
2025/02/14 | 日証協 | 187,205株 | +34.81% | 279,785株 | +55.36% | 159,236株 | +14.5% | 20,787株 | +196.96% |
2025/02/07 | 日証協 | 138,868株 | +3.54% | 180,083株 | +29.43% | 139,075株 | -3.17% | 7,000株 | -52.42% |
2025/01/31 | 日証協 | 134,125株 | -10.33% | 139,140株 | +10.84% | 143,626株 | -5.02% | 14,712株 | +155.37% |
2025/01/24 | 日証協 | 149,568株 | -8.68% | 125,530株 | -28.83% | 151,223株 | -15.67% | 5,761株 | +37.33% |
2025/01/17 | 日証協 | 163,776株 | -8.57% | 176,392株 | -23.18% | 179,323株 | -6.06% | 4,195株 | -88.71% |
2025/01/10 | 日証協 | 179,122株 | -2.92% | 229,605株 | +226.68% | 190,890株 | +1.87% | 37,166株 | +603.1% |
2024/12/30 | 日証協 | 184,519株 | +1.71% | 70,284株 | -76.67% | 187,390株 | +4.81% | 5,286株 | -59.95% |
2024/12/27 | 日証協 | 181,419株 | -4.06% | 301,316株 | +35.34% | 178,790株 | -12.39% | 13,200株 | +10.24% |
2024/12/20 | 日証協 | 189,093株 | -15.41% | 222,644株 | +11.72% | 204,066株 | -3.38% | 11,974株 | -55.88% |
2024/12/13 | 日証協 | 223,544株 | -1.29% | 199,284株 | +7.56% | 211,199株 | +4.14% | 27,138株 | +9.96% |
2024/12/06 | 日証協 | 226,470株 | -0.2% | 185,269株 | -19.85% | 202,810株 | +1.68% | 24,679株 | +107.46% |
2024/11/29 | 日証協 | 226,932株 | +2.07% | 231,146株 | -30.25% | 199,456株 | +1.67% | 11,896株 | +1.01% |
2024/11/22 | 日証協 | 222,335株 | -1.62% | 331,390株 | +55.96% | 196,175株 | -0.56% | 11,777株 | -47.98% |
2024/11/15 | 日証協 | 226,000株 | +4.02% | 212,479株 | -51.45% | 197,276株 | -4.55% | 22,639株 | +25.8% |
2024/11/08 | 日証協 | 217,260株 | -24.3% | 437,682株 | +6.47% | 206,690株 | -8.38% | 17,996株 | -84.74% |
2024/11/01 | 日証協 | 287,013株 | +59.02% | 411,077株 | +18.58% | 225,590株 | +43.73% | 117,920株 | +1895.26% |
2024/10/25 | 日証協 | 180,491株 | -2.48% | 346,674株 | +157.47% | 156,955株 | -0.28% | 5,910株 | -70.25% |
2024/10/18 | 日証協 | 185,088株 | -1.85% | 134,644株 | -56.39% | 157,390株 | -12% | 19,865株 | +46.07% |
※株式分割は考慮していませんのでご注意ください。
Page Top